Venrock Healthcare Capital Partners III L.P. 13D and 13G filings for Applied Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 6:11 pm Purchase |
2024-12-31 | 13G | Applied Therapeutics, Inc. APLT |
Venrock Healthcare Capital Partners III L.P. | 11,805,301 9.900% |
149,236 (+1.28%) |
Filing |
| 2025-02-03 7:43 pm Purchase |
2025-01-30 | 13G | Applied Therapeutics, Inc. APLT |
Venrock Healthcare Capital Partners III L.P. | 5,012,796 10.100% |
5,012,796 (New Position) |
Filing |
| 2024-11-14 5:47 pm Purchase |
2024-09-30 | 13G | Applied Therapeutics, Inc. APLT |
Venrock Healthcare Capital Partners III L.P. | 11,656,065 9.990% |
3,778,248 (+47.96%) |
Filing |
| 2024-02-14 9:20 pm Purchase |
2023-12-31 | 13G | Applied Therapeutics, Inc. APLT |
Venrock Healthcare Capital Partners III L.P. | 7,877,817 9.990% |
2,080,232 (+35.88%) |
Filing |
| 2023-05-08 4:05 pm Purchase |
2023-04-26 | 13G | Applied Therapeutics, Inc. APLT |
Venrock Healthcare Capital Partners III L.P. | 5,797,585 9.990% |
5,797,585 (New Position) |
Filing |